Adelaide Research & Scholarship: Search

Search

Results 1-10 of 21 (Search time: 0.002 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2001	Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer	Han, G.; Foster, B.; Mistry, S.; Buchanan, G.; Harris, J.; Tilley, W.; Greenberg, N.
	2001	Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function	Buchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
	2001	Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase	Butler, L.; Webb, Y.; Agus, D.; Higgins, B.; Tolentino, T.; Kutko, M.; LaQuaglia, M.; Drobnjak, M.; Cordon-Cardo, C.; Scher, H.; Breslow, R.; Richon, V.; Rifkind, R.; Marks, P.
	2019	Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer	Watt, M.J.; Clark, A.K.; Selth, L.A.; Haynes, V.R.; Lister, N.; Rebello, R.; Porter, L.H.; Niranjan, B.; Whitby, S.T.; Lo, J.; Huang, C.; Schittenhelm, R.B.; Anderson, K.E.; Furic, L.; Wijayaratne, P.R.; Matzaris, M.; Montgomery, M.K.; Papargiris, M.; Norden, S.; Febbraio, M.; et al.
	2021	ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer	Centenera, M.M.; Scott, J.S.; Machiels, J.; Nassar, Z.D.; Miller, D.C.; Zinonos, I.; Dehairs, J.; Burvenich, I.J.G.; Zadra, G.; Chetta, P.; Bango, C.; Evergren, E.; Ryan, N.K.; Gillis, J.L.; Mah, C.Y.; Tieu, T.; Hanson, A.R.; Carelli, R.; Bloch, K.; Panagopoulos, V.; et al.
	2016	Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target	Asim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
	2023	Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts	Wu, Y.; Clark, K.C.; Niranjan, B.; Chüeh, A.C.; Horvath, L.G.; Taylor, R.A.; Daly, R.J.
	2012	Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease	Selth, L.; Townley, S.; Gillis, J.; Ochnik, A.; Murti, K.; Macfarlane, R.; Chi, K.; Marshall, V.; Tilley, W.; Butler, L.
	2013	Targeting amino acid transport in metastatic castration-resistant prostate cancer: Effects on cell cycle, cell growth, and tumor development	Wang, Q.; Tiffen, J.; Bailey, C.; Lehman, M.; Ritchie, W.; Fazli, L.; Metierre, C.; Feng, Y.; Li, E.; Gleave, M.; Buchanan, G.; Nelson, C.; Rasko, J.; Holst, J.
	2013	Lack of high-dose radiation mediated prostate cancer promotion and low-dose radiation adaptive response in the TRAMP mouse model	Lawrence, M.; Ormsby, R.; Blyth, B.; Bezak, E.; England, G.; Newman, M.; Tilley, W.; Sykes, P.